COPD is associated with left ventricular size and function: Results from COSYCONET

Peter Alter (Marburg, Germany), Peter Alter, Annika Karch, Henrik Watz, Armin Koch, Tobias Welte, Holger Schulz, Rudolf Jörres, Claus Vogelmeier

Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Session: COPD and lung function: risk factors and outcomes
Session type: Poster Discussion
Number: 613
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Peter Alter (Marburg, Germany), Peter Alter, Annika Karch, Henrik Watz, Armin Koch, Tobias Welte, Holger Schulz, Rudolf Jörres, Claus Vogelmeier. COPD is associated with left ventricular size and function: Results from COSYCONET. Eur Respir J 2015; 46: Suppl. 59, 613

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Right ventricle dysfunction predicts prognosis in COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015

Influences of lung and left heart function on respiratory symptoms in COPD: Results from the COSYCONET cohort
Source: International Congress 2019 – New insights into respiratory function testing
Year: 2019




COPD influences on left heart wall stress — An analysis of the COSYCONET cohort
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016

Lung function is associated with left ventricular wall stress in coincident COPD and heart failure
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015

Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH)
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Left heart dysfunction in COPD- Ignored combination
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Left ventricular dysfunction in patients with COPD: Inflammation and endothelial dysfunction
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Physical and psychological impairments in COPD patients with and without reduced left ventricular ejection fraction
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015

COPD: Left ventricular dysfunction, systemic inflammation and endothelial dysfunction
Source: International Congress 2014 – Markers
Year: 2014


Cardiac structure and function at baseline in the DEFLATA study: The impact of lung hyperinflation and its relationship with the GOLD classification
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Response of right ventricular myocardial function to endoscopic lung volume reduction in patients with advanced emphysema
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014

Sarcopenia and associated factors in older adults with COPD: Results from the SABE-Bogota cohort study
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016


Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


LATE-BREAKING ABSTRACT: Heart failure with preserved ejection fraction in patients with chronic obstructive pulmonary disease exacerbation is associated with poor long-term survival
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF
Source: Eur Respir J 2001; 18: 298-305
Year: 2001



Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction ? A case-control study.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018



Is there benefit from proactive case-detection of left ventricular systolic dysfunction (LVSD) using BNP in patients with advanced COPD?
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016